Table of Contents Author Guidelines Submit a Manuscript
Pulmonary Medicine
Volume 2012, Article ID 834826, 14 pages
http://dx.doi.org/10.1155/2012/834826
Review Article

Virus Infection-Induced Bronchial Asthma Exacerbation

Department of Advanced Preventive, Medicine for Infectious Disease, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan

Received 1 December 2011; Revised 1 May 2012; Accepted 22 June 2012

Academic Editor: S. L. Johnston

Copyright © 2012 Mutsuo Yamaya. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. E. Minor, E. C. Dick, and J. W. Baker, “Rhinovirus and influenza type A infections as precipitants of asthma,” American Review of Respiratory Disease, vol. 113, no. 2, pp. 149–153, 1976. View at Google Scholar · View at Scopus
  2. R. E. Gama, P. R. Horsnell, P. J. Hughes et al., “Amplification of rhinovirus specific nucleic acids from clinical samples using the polymerase chain reaction,” Journal of Medical Virology, vol. 28, no. 2, pp. 73–77, 1989. View at Google Scholar · View at Scopus
  3. P. K. Pattemore, S. L. Johnston, and P. G. Bardin, “Viruses as precipitants of asthma symptoms. I. Epidemiology,” Clinical and Experimental Allergy, vol. 22, no. 3, pp. 325–336, 1992. View at Google Scholar · View at Scopus
  4. K. G. Nicholson, J. Kent, and D. C. Ireland, “Respiratory viruses and exacerbations of asthma in adults,” British Medical Journal, vol. 307, no. 6910, pp. 982–986, 1993. View at Google Scholar · View at Scopus
  5. S. L. Johnston, P. K. Pattemore, G. Sanderson et al., “Community study of role of viral infections in exacerbations of asthma in 9-11 year old children,” British Medical Journal, vol. 310, no. 6989, pp. 1225–1229, 1995. View at Google Scholar · View at Scopus
  6. E. Arruda, A. Pitkäranta, T. J. Witek, C. A. Doyle, and F. G. Hayden, “Frequency and natural history of rhinovirus infections in adults during autumn,” Journal of Clinical Microbiology, vol. 35, no. 11, pp. 2864–2868, 1997. View at Google Scholar · View at Scopus
  7. R. A. Levandowski, C. W. Weaver, and G. G. Jackson, “Nasal-secretion leukocyte populations determined by flow cytometry during acute rhinovirus infection,” Journal of Medical Virology, vol. 25, no. 4, pp. 423–432, 1988. View at Google Scholar · View at Scopus
  8. R. B. Turner, “The role of neutrophils in the pathogenesis of rhinovirus infections,” Pediatric Infectious Disease Journal, vol. 9, no. 11, pp. 832–835, 1990. View at Google Scholar · View at Scopus
  9. P. G. Bardin, D. J. Fraenkel, G. Sanderson, F. Lampe, and S. T. Holgate, “Lower airways inflammaton/response during rhinovirus colds,” International Archives of Allergy and Immunology, vol. 107, no. 1–3, pp. 127–129, 1995. View at Google Scholar · View at Scopus
  10. D. J. Fraenkel, P. G. Bardin, G. Sanderson, F. Lampe, S. L. Johnston, and S. T. Holgate, “Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects,” American Journal of Respiratory and Critical Care Medicine, vol. 151, no. 3, pp. 879–886, 1995. View at Google Scholar · View at Scopus
  11. H. W. F. M. de Gouw, K. Grünberg, R. Schot, A. C. M. Kroes, E. C. Dick, and P. J. Sterk, “Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects,” European Respiratory Journal, vol. 11, no. 1, pp. 126–132, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. M. C. Subauste, D. B. Jacoby, S. M. Richards, and D. Proud, “Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure,” Journal of Clinical Investigation, vol. 96, no. 1, pp. 549–557, 1995. View at Google Scholar · View at Scopus
  13. Z. Zhu, W. Tang, A. Ray et al., “Rhinovirus stimulation of lnterleukin-6 in vivo and in vitro: evidence for nuclear factor κB-dependent transcriptional activation,” Journal of Clinical Investigation, vol. 97, no. 2, pp. 421–430, 1996. View at Google Scholar · View at Scopus
  14. M. Terajima, M. Yamaya, K. Sekizawa et al., “Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1β,” American Journal of Physiology, vol. 273, no. 4, pp. L749–L759, 1997. View at Google Scholar · View at Scopus
  15. M. Yamaya, K. Sekizawa, T. Suzuki et al., “Infection of human respiratory submucosal glands with rhinovirus: effects on cytokine and ICAM-1 production,” American Journal of Physiology, vol. 277, no. 2, pp. L362–L371, 1999. View at Google Scholar · View at Scopus
  16. W. W. Busse, C. A. Swenson, E. C. Borden, M. W. Treuhaft, and E. C. Dick, “Effect of influenza A virus on leukocyte histamine release,” Journal of Allergy and Clinical Immunology, vol. 71, no. 4, pp. 382–388, 1983. View at Google Scholar · View at Scopus
  17. T. Chonmaitree, M. A. Lett-Brown, Y. Tsong, A. S. Goldman, and S. Baron, “Role of interferon in leukocyte histamine release caused by common respiratory viruses,” Journal of Infectious Diseases, vol. 157, no. 1, pp. 127–132, 1988. View at Google Scholar · View at Scopus
  18. W. J. Calhoun, C. A. Swenson, E. C. Dick, L. B. Schwartz, R. F. Lemanske, and W. W. Busse, “Experimental rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects,” American Review of Respiratory Disease, vol. 144, no. 6, pp. 1267–1273, 1991. View at Google Scholar · View at Scopus
  19. H. Yasuda, T. Suzuki, K. Zayasu et al., “Inflammatory and bronchospastic factors in asthma exacerbations caused by upper respiratory tract infections,” Tohoku Journal of Experimental Medicine, vol. 207, no. 2, pp. 109–118, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Hakonarson, N. Maskeri, C. Carter, R. L. Hodinka, D. Campbell, and M. M. Grunstein, “Mechanism of rhinovirus-induced changes in airway smooth muscle responsiveness,” Journal of Clinical Investigation, vol. 102, no. 9, pp. 1732–1741, 1998. View at Google Scholar · View at Scopus
  21. M. M. Grunstein, H. Hakonarson, N. Maskeri, and S. Chuang, “Autocrine cytokine signaling mediates effects of rhinovirus on airway responsiveness,” American Journal of Physiology, vol. 278, no. 6, pp. L1146–L1153, 2000. View at Google Scholar · View at Scopus
  22. P. A. B. Wark, S. L. Johnston, F. Bucchieri et al., “Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus,” Journal of Experimental Medicine, vol. 201, no. 6, pp. 937–947, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Contoli, S. D. Message, V. Laza-Stanca et al., “Role of deficient type III interferon-λ production in asthma exacerbations,” Nature Medicine, vol. 12, no. 9, pp. 1023–1026, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Iikura, T. Katsunuma, S. Saika et al., “Peripheral blood mononuclear cells from patients with bronchial asthma show impaired innate immune responses to rhinovirus in vitro,” International Archives of Allergy and Immunology, vol. 155, no. 1, pp. 27–33, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. L. M. Teran, S. L. Johnston, J. M. Schröder, M. K. Church, and S. T. Holgate, “Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus-induced asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 155, no. 4, pp. 1362–1366, 1997. View at Google Scholar · View at Scopus
  26. P. W. Heymann, G. P. Rakes, A. D. Hogan, J. M. Ingram, G. E. Hoover, and T. A. E. Platts-Mills, “Assessment of eosinophils, viruses and IgE antibody in wheezing infants and children,” International Archives of Allergy and Immunology, vol. 107, no. 1–3, pp. 380–382, 1995. View at Google Scholar · View at Scopus
  27. K. Grünberg, H. H. Smits, M. C. Timmers et al., “Experimental rhinovirus 16 infection: effects on cell differentials and soluble markers in sputum in asthmatic subjects,” American Journal of Respiratory and Critical Care Medicine, vol. 156, no. 2, pp. 609–616, 1997. View at Google Scholar · View at Scopus
  28. R. Deng, M. Lu, C. Korteweg et al., “Distinctly different expression of cytokines and chemokines in the lungs of two H5N1 avian influenza patients,” Journal of Pathology, vol. 216, no. 3, pp. 328–336, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Yamaya, K. Sekizawa, S. Ishizuka, M. Monma, K. Mizuta, and H. Sasaki, “Increased carbon monoxide in exhaled air of subjects with upper respiratory tract infections,” American Journal of Respiratory and Critical Care Medicine, vol. 158, no. 1, pp. 311–314, 1998. View at Google Scholar · View at Scopus
  30. M. Yamara, K. Sekizawa, S. Ishizuka, M. Monma, and H. Sasaki, “Exhaled carbon monoxide levels during treatment of acute asthma,” European Respiratory Journal, vol. 13, no. 4, pp. 757–760, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Hashimoto, N. Igarashi, A. Yachie, T. Miyawaki, and T. Sato, “The relationship between serum levels of interleukin-6 and thyroid hormone in children with acute respiratory infection,” Journal of Clinical Endocrinology and Metabolism, vol. 78, no. 2, pp. 288–291, 1994. View at Publisher · View at Google Scholar · View at Scopus
  32. O. Einarsson, G. P. Geba, Z. Zhu, M. Landry, and J. A. Elias, “Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness,” Journal of Clinical Investigation, vol. 97, no. 4, pp. 915–924, 1996. View at Google Scholar · View at Scopus
  33. M. R. Edwards, M. W. Johnson, and S. L. Johnston, “Combination therapy: synergistic suppression of virus-induced chemokines in airway epithelial cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 34, no. 5, pp. 616–624, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. M. R. Edwards, J. Haas Jr., R. A. Panettieri, M. Johnson, and S. L. Johnston, “Corticosteroids and β2 agonists differentially regulate rhinovirus-induced interleukin-6 via distinct cis-acting elements,” Journal of Biological Chemistry, vol. 282, no. 21, pp. 15366–15375, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. C. L. Skevaki, I. Christodoulou, I. S. Spyridaki et al., “Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus,” Clinical and Experimental Allergy, vol. 39, no. 11, pp. 1700–1710, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Suzuki, M. Yamaya, K. Sekizawa et al., “Effects of dexamethasone on rhinovirus infection in cultured human tracheal epithelial cells,” American Journal of Physiology, vol. 278, no. 3, pp. L560–L571, 2000. View at Google Scholar · View at Scopus
  37. T. Suzuki, M. Yamaya, K. Sekizawa et al., “Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 8, pp. 1113–1118, 2002. View at Google Scholar · View at Scopus
  38. H. Yasuda, M. Yamaya, T. Sasaki et al., “Carbocisteine inhibits rhinovirus infection in human tracheal epithelial cells,” European Respiratory Journal, vol. 28, no. 1, pp. 51–58, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Yamaya, H. Nishimura, Y. Hatachi et al., “Procaterol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells,” European Journal of Pharmacology, vol. 650, no. 1, pp. 431–444, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Yamaya, H. Nishimura, Y. Hatachi et al., “Inhibitory effects of tiotropium on rhinovirus infection in human airway epithelial cells,” European Respiratory Journal, vol. 40, no. 1, pp. 122–132, 2012. View at Google Scholar
  41. M. K. Schroth, E. Grimm, P. Frindt et al., “Rhinovirus replication causes RANTES production in primary bronchial epithelial cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 20, no. 6, pp. 1220–1228, 1999. View at Google Scholar · View at Scopus
  42. N. G. Papadopoulos, A. Papi, J. Meyer et al., “Rhinovirus infection up-regulates eotaxin and eotaxin-2 expression in bronchial epithelial cells,” Clinical and Experimental Allergy, vol. 31, no. 7, pp. 1060–1066, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Suzuki, M. Yamaya, M. Kamanaka et al., “Type 2 rhinovirus infection of cultured human tracheal epithelial cells: role of LDL receptor,” American Journal of Physiology, vol. 280, no. 3, pp. L409–L420, 2001. View at Google Scholar · View at Scopus
  44. E. Furukuwa, T. Ohrui, M. Yamaya et al., “Human airway submucosal glands augment eosinophil chemotaxis during rhinovirus infection,” Clinical and Experimental Allergy, vol. 34, no. 5, pp. 704–711, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Sasaki, M. Yamaya, H. Yasuda et al., “The proton pump inhibitor lansoprazole inhibits rhinovirus infection in cultured human tracheal epithelial cells,” European Journal of Pharmacology, vol. 509, no. 2-3, pp. 201–210, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Yamaya, T. Sasaki, H. Yasuda et al., “Hochu-ekki-to inhibits rhinovirus infection in human tracheal epithelial cells,” British Journal of Pharmacology, vol. 150, no. 6, pp. 702–710, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Koetzler, R. S. Zaheer, S. Wiehler, N. S. Holden, M. A. Giembycz, and D. Proud, “Nitric oxide inhibits human rhinovirus-induced transcriptional activation of CXCL10 in airway epithelial cells,” Journal of Allergy and Clinical Immunology, vol. 123, no. 1, pp. 201–208.e9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. J. A. Cakebread, Y. Xu, C. Grainge et al., “Exogenous IFN-β has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus,” Journal of Allergy and Clinical Immunology, vol. 127, no. 5, pp. 1148–1154.e9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Inoue, M. Yamaya, H. Kubo et al., “Mechanisms of mucin production by rhinovirus infection in cultured human airway epithelial cells,” Respiratory Physiology and Neurobiology, vol. 154, no. 3, pp. 484–499, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. Z. T. Handzel, W. W. Busse, J. B. Sedgwick et al., “Eosinophils bind rhinovirus and activate virus-specific T cells,” Journal of Immunology, vol. 160, no. 3, pp. 1279–1284, 1998. View at Google Scholar · View at Scopus
  51. J. E. Gern, R. Vrtis, E. A. B. Kelly, E. C. Dick, and W. W. Busse, “Rhinovirus produces nonspecific activation of lymphocytes through a monocyte-dependent mechanism,” Journal of Immunology, vol. 157, no. 4, pp. 1605–1612, 1996. View at Google Scholar · View at Scopus
  52. R. F. Lemanske Jr., E. C. Dick, C. A. Swenson, R. F. Vrtis, and W. W. Busse, “Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions,” Journal of Clinical Investigation, vol. 83, no. 1, pp. 1–10, 1989. View at Google Scholar · View at Scopus
  53. M. Hosoda, M. Yamaya, T. Suzuki et al., “Effects of rhinovirus infection on histamine and cytokine production by cell lines from human mast cells and basophils,” Journal of Immunology, vol. 169, no. 3, pp. 1482–1491, 2002. View at Google Scholar · View at Scopus
  54. J. E. Gern, E. C. Dick, W. M. Lee et al., “Rhinovirus enters but does not replicate inside monocytes and airway macrophages,” Journal of Immunology, vol. 156, no. 2, pp. 621–627, 1996. View at Google Scholar · View at Scopus
  55. M. Yamaya, K. Shinya, Y. Hatachi et al., “Clarithromycin inhibits type A seasonal influenza virus infection in human airway epithelial cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 333, no. 1, pp. 81–90, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Yamaya, H. Nishimura, K. Shinya et al., “Inhibitory effects of carbocisteine on type A seasonal influenza virus infection in human airway epithelial cells,” American Journal of Physiology, vol. 299, no. 2, pp. L160–L168, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Wang, T. Q. Le, N. Kurihara et al., “Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza,” Journal of Infectious Diseases, vol. 202, no. 7, pp. 991–1001, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Ida, J. J. Hooks, R. P. Siraganian, and A. L. Notkins, “Enhancement of IgE mediated histamine release from human basophils by viruses: role of interferon,” Journal of Experimental Medicine, vol. 145, no. 4, pp. 892–906, 1977. View at Google Scholar · View at Scopus
  59. T. L. Noah and S. Becker, “Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line,” American Journal of Physiology, vol. 265, no. 5, pp. L472–L478, 1993. View at Google Scholar · View at Scopus
  60. R. A. Tripp, C. Oshansky, and R. Alvarez, “Cytokines and respiratory syncytial virus infection,” Proceedings of the American Thoracic Society, vol. 2, no. 2, pp. 147–149, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Asada, M. Yoshida, T. Suzuki et al., “Macrolide antibiotics inhibit respiratory syncytial virus infection in human airway epithelial cells,” Antiviral Research, vol. 83, no. 2, pp. 191–200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. P. J. Barnes, “Scientific rationale for using a single inhaler for asthma control,” European Respiratory Journal, vol. 29, no. 3, pp. 587–595, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. S. L. Johnston, P. K. Pattemore, G. Sanderson et al., “The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis,” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 3, pp. 654–660, 1996. View at Google Scholar · View at Scopus
  64. T. E. Minor, J. W. Baker, and E. C. Dick, “Greater frequency of viral respiratory infections in asthmatic children as compared with their nonasthmatic siblings,” Journal of Pediatrics, vol. 85, no. 4, pp. 472–477, 1974. View at Google Scholar · View at Scopus
  65. A. Fujitsuka, H. Tsukagoshi, M. Arakawa et al., “A molecular epidemiological study of respiratory viruses detected in Japanese children with acute wheezing illness,” BMC Infectious Diseases, vol. 11, article 168, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. S. Hasegawa, R. Hirano, K. Hashimoto, Y. Haneda, K. Shirabe, and T. Ichiyama, “Characteristics of atopic children with pandemic H1N1 influenza viral infection: pandemic H1N1 influenza reveals “occult” asthma of childhood,” Pediatric Allergy and Immunology, vol. 22, no. 1, pp. e119–e123, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. C. Nathan, “Nitric oxide as a secretory product of mammalian cells,” FASEB Journal, vol. 6, no. 12, pp. 3051–3064, 1992. View at Google Scholar · View at Scopus
  68. K. Alving, E. Weitzberg, and J. M. Lundberg, “Increased amount of nitric oxide in exhaled air of asthmatics,” European Respiratory Journal, vol. 6, no. 9, pp. 1368–1370, 1993. View at Google Scholar · View at Scopus
  69. S. A. Kharitonov, D. Yates, R. A. Robbins, R. Logan-Sinclair, E. A. Shinebourne, and P. J. Barnes, “Increased nitric oxide in exhaled air of asthmatic patients,” The Lancet, vol. 343, no. 8890, pp. 133–135, 1994. View at Publisher · View at Google Scholar · View at Scopus
  70. M. G. Persson, O. Zetterström, V. Agrenius, E. Ihre, and L. E. Gustafsson, “Single-breath nitric oxide measurements in asthmatic patients and smokers,” The Lancet, vol. 343, no. 8890, pp. 146–147, 1994. View at Publisher · View at Google Scholar · View at Scopus
  71. A. F. Massaro, B. Gaston, D. Kita, C. Fanta, J. S. Stamler, and J. M. Drazen, “Expired nitric oxide levels during treatment of acute asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 152, no. 2, pp. 800–803, 1995. View at Google Scholar · View at Scopus
  72. K. Zayasu, K. Sekizawa, S. Okinaga, M. Yamaya, T. Ohrui, and H. Sasaki, “Increased carbon monoxide in exhaled air of asthmatic patients,” American Journal of Respiratory and Critical Care Medicine, vol. 156, no. 4, pp. 1140–1143, 1997. View at Google Scholar · View at Scopus
  73. C. O. Olopade, M. Zakkar, W. I. Swedler, and I. Rubinstein, “Exhaled pentane levels in acute asthma,” Chest, vol. 111, no. 4, pp. 862–865, 1997. View at Google Scholar · View at Scopus
  74. P. Paredi, S. A. Kharitonov, and P. J. Barnes, “Elevation of exhaled ethane concentration in asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 4, pp. 1450–1454, 2000. View at Google Scholar · View at Scopus
  75. S. Moncada and E. A. Higgs, “Molecular mechanisms and therapeutic strategies related to nitric oxide,” FASEB Journal, vol. 9, no. 13, pp. 1319–1330, 1995. View at Google Scholar · View at Scopus
  76. R. A. Robbins, P. J. Barnes, D. R. Springall et al., “Expression of inducible nitric oxide in human lung epithelial cells,” Biochemical and Biophysical Research Communications, vol. 203, no. 1, pp. 209–218, 1994. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Asada, M. Yoshida, T. Suzuki et al., “Macrolide antibiotics inhibit respiratory syncytial virus infection in human airway epithelial cells,” Antiviral Research, vol. 83, no. 2, pp. 191–200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. T. F. Leung, M. Y. To, A. C. M. Yeung, Y. S. Wong, G. W. K. Wong, and P. K. S. Chan, “Multiplex molecular detection of respiratory pathogens in children with asthma exacerbation,” Chest, vol. 137, no. 2, pp. 348–354, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. M. D. Maines, “Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications,” FASEB Journal, vol. 2, no. 10, pp. 2557–2568, 1988. View at Google Scholar · View at Scopus
  80. H. Yasuda, M. Yamaya, K. Nakayama et al., “Increased arterial carboxyhemoglobin concentrations in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 11, pp. 1246–1251, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. P. Paredi, M. J. Leckie, I. Horvath, L. Allegra, S. A. Kharitonov, and P. J. Barnes, “Changes in exhaled carbon monoxide and nitric oxide levels following allergen challenge in patients with asthma,” European Respiratory Journal, vol. 13, no. 1, pp. 48–52, 1999. View at Publisher · View at Google Scholar · View at Scopus
  82. I. Horváth, W. MacNee, F. J. Kelly et al., “"Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases", summary of the ERS Research Seminar in Budapest, Hungary, September, 1999,” European Respiratory Journal, vol. 18, no. 2, pp. 420–430, 2001. View at Publisher · View at Google Scholar · View at Scopus
  83. M. Yamaya, M. Hosoda, S. Ishizuka et al., “Relation between exhaled carbon monoxide levels and clinical severity of asthma,” Clinical and Experimental Allergy, vol. 31, no. 3, pp. 417–422, 2001. View at Publisher · View at Google Scholar · View at Scopus
  84. T. Ohrui, M. Yamaya, K. Sekizawa et al., “Effects of rhinovirus infection on hydrogen peroxideinduced alterations of barrier function in the cultured human tracheal epithelium,” American Journal of Respiratory and Critical Care Medicine, vol. 158, no. 1, pp. 241–248, 1998. View at Google Scholar · View at Scopus
  85. S. Akira, T. Hirano, T. Taga, and T. Kishimoto, “Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF),” FASEB Journal, vol. 4, no. 11, pp. 2860–2867, 1990. View at Google Scholar · View at Scopus
  86. E. J. Leonard and T. Yoshimura, “Neutrophil attractant/activation protein-1 (NAP-1 [interleukin-8]),” American Journal of Respiratory Cell and Molecular Biology, vol. 2, no. 6, pp. 479–486, 1990. View at Google Scholar · View at Scopus
  87. A. F. Lopez, D. J. Williamson, and J. R. Gamble, “Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival,” Journal of Clinical Investigation, vol. 78, no. 5, pp. 1220–1228, 1986. View at Google Scholar · View at Scopus
  88. A. Papi and S. L. Johnston, “Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-κB-mediated transcription,” Journal of Biological Chemistry, vol. 274, no. 14, pp. 9707–9720, 1999. View at Publisher · View at Google Scholar · View at Scopus
  89. T. Suzuki, M. Yamaya, K. Sekizawa et al., “Bafilomycin A1 inhibits rhinovirus infection in human airway epithelium: effects on endosome and ICAM-1,” American Journal of Physiology, vol. 280, no. 6, pp. L1115–L1127, 2001. View at Google Scholar · View at Scopus
  90. J. M. Greve, G. Davis, A. M. Meyer et al., “The major human rhinovirus receptor is ICAM-1,” Cell, vol. 56, no. 5, pp. 839–847, 1989. View at Google Scholar · View at Scopus
  91. J. E. Tomassini, D. Graham, C. M. DeWitt, D. W. Lineberger, J. A. Rodkey, and R. J. Colonno, “cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 13, pp. 4907–4911, 1989. View at Google Scholar · View at Scopus
  92. C. D. Wegner, R. H. Gundel, P. Reilly, N. Haynes, L. G. Letts, and R. Rothlein, “Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma,” Science, vol. 247, no. 4941, pp. 456–459, 1990. View at Google Scholar · View at Scopus
  93. S. K. Huang, H. Q. Xiao, J. Kleine-Tebbe et al., “IL-13 expression at the sites of allergen challenge in patients with asthma,” Journal of Immunology, vol. 155, no. 5, pp. 2688–2694, 1995. View at Google Scholar · View at Scopus
  94. M. E. Lachowicz-Scroggins, H. A. Boushey, W. E. Finkbeiner, and J. H. Widdicombe, “Interleukin-13-induced mucous metaplasia increases susceptibility of human airway epithelium to rhinovirus infection,” American Journal of Respiratory Cell and Molecular Biology, vol. 43, no. 6, pp. 652–661, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. B. Winther, J. M. Gwaltney, and J. O. Hendley, “Respiratory virus infection of monolayer cultures of human nasal epithelial cells,” American Review of Respiratory Disease, vol. 141, no. 4, pp. 839–845, 1990. View at Google Scholar · View at Scopus
  96. D. B. Jacoby, J. Tamaoki, D. B. Borson, and J. A. Nadel, “Influenza infection causes airway hyperresponsiveness by decreasing enkephalinase,” Journal of Applied Physiology, vol. 64, no. 6, pp. 2653–2658, 1988. View at Google Scholar · View at Scopus
  97. S. J. Galli, “Seminars in medicine of the Beth Israel Hospital, Boston: new concepts about the mast cell,” The New England Journal of Medicine, vol. 328, no. 4, pp. 257–265, 1993. View at Publisher · View at Google Scholar · View at Scopus
  98. R. Rothlein, M. Czajkowski, M. M. O'Neill, S. D. Marlin, E. Mainolfi, and V. J. Merluzzi, “Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines: regulation by pharmacologic agents and neutralizing antibodies,” Journal of Immunology, vol. 141, no. 5, pp. 1665–1669, 1988. View at Google Scholar · View at Scopus
  99. I. M. Balfour-Lynn, H. B. Valman, R. Wellings, A. D. B. Webster, G. W. Taylor, and M. Silverman, “Tumour necrosis factor-α and leukotriene E4 production in wheezy infants,” Clinical and Experimental Allergy, vol. 24, no. 2, pp. 121–126, 1994. View at Publisher · View at Google Scholar · View at Scopus
  100. S. Z. Anticevich, J. M. Hughes, J. L. Black, and C. L. Armour, “Induction of human airway hyperresponsiveness by tumour necrosis factor-α,” European Journal of Pharmacology, vol. 284, no. 1-2, pp. 221–225, 1995. View at Publisher · View at Google Scholar · View at Scopus
  101. B. D. Rudd, J. J. Smit, R. A. Flavell et al., “Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection,” Journal of Immunology, vol. 176, no. 3, pp. 1937–1942, 2006. View at Google Scholar · View at Scopus
  102. M. R. Murawski, G. N. Bowen, A. M. Cerny et al., “Respiratory syncytial virus activates innate immunity through toll-like receptor 2,” Journal of Virology, vol. 83, no. 3, pp. 1492–1500, 2009. View at Publisher · View at Google Scholar · View at Scopus
  103. L. Slater, N. W. Bartlett, J. J. Haas et al., “Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium,” PLoS Pathogens, vol. 6, no. 11, Article ID e1001178, 2010. View at Publisher · View at Google Scholar · View at Scopus
  104. N. Lukacs, J. Smit, D. Lindell, and M. Schaller, “Respiratory syncytial virus-induced pulmonary disease and exacerbation of allergic asthma,” Contributions to Microbiology, vol. 14, pp. 68–82, 2007. View at Publisher · View at Google Scholar · View at Scopus
  105. B. G. G. Oliver, S. L. Johnston, M. Baraket et al., “Increased proinflammatory responses from asthmatic human airway smooth muscle cells in response to rhinovirus infection,” Respiratory Research, vol. 7, article 71, 2006. View at Publisher · View at Google Scholar · View at Scopus
  106. L. Pauling, “The significance of the evidence about ascorbic acid and the common cold,” Proceedings of the National Academy of Sciences of the United States of America, vol. 68, no. 11, pp. 2678–2681, 1971. View at Google Scholar · View at Scopus
  107. H. Hemilä, “Vitamin C supplementation and the common cold—was Linus Pauling right or wrong?” International Journal for Vitamin and Nutrition Research, vol. 67, no. 5, pp. 329–335, 1997. View at Google Scholar · View at Scopus
  108. S. Marshall, “Zinc gluconate and the common cold: review of randomized controlled trials,” Canadian Family Physician, vol. 44, pp. 1037–1042, 1998. View at Google Scholar · View at Scopus
  109. M. L. Macknin, M. Piedmonte, C. Calendine, J. Janosky, and E. Wald, “Zinc gluconate lozenges for treating the common cold in children: a randomized controlled trial,” Journal of the American Medical Association, vol. 279, no. 24, pp. 1962–1967, 1998. View at Publisher · View at Google Scholar · View at Scopus
  110. A. T. Hadfield, G. D. Diana, and M. G. Rossmann, “Analysis of three structurally related antiviral compounds in complex with human rhinovirus 16,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 26, pp. 14730–14735, 1999. View at Publisher · View at Google Scholar · View at Scopus
  111. J. K. Lewis, B. Bothner, T. J. Smith, and G. Siuzdak, “Antiviral agent blocks breathing of the common cold virus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 12, pp. 6774–6778, 1998. View at Publisher · View at Google Scholar · View at Scopus
  112. E. D. Huguenel, D. Cohn, D. P. Dockum et al., “Prevention of rhinovirus infection in chimpanzees by soluble intercellular adhesion molecule-1,” American Journal of Respiratory and Critical Care Medicine, vol. 155, no. 4, pp. 1206–1210, 1997. View at Google Scholar · View at Scopus
  113. R. B. Turner, M. T. Wecker, G. Pohl et al., “Efficacy of Tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial,” Journal of the American Medical Association, vol. 281, no. 19, pp. 1797–1804, 1999. View at Publisher · View at Google Scholar · View at Scopus
  114. G. Witherell, “AG-7088 Pfizer,” Current Opinion in Investigational Drugs, vol. 1, no. 3, pp. 297–302, 2000. View at Google Scholar · View at Scopus
  115. F. G. Hayden, G. J. Hipskind, D. H. Woerner et al., “Intranasal pirodavir (R77,975) treatment of rhinovirus colds,” Antimicrobial Agents and Chemotherapy, vol. 39, no. 2, pp. 290–294, 1995. View at Google Scholar · View at Scopus
  116. B. M. Farr, J. M. Gwaltney, K. F. Adams, and F. G. Hayden, “Intranasal interferon-α2 for prevention of natural rhinovirus colds,” Antimicrobial Agents and Chemotherapy, vol. 26, no. 1, pp. 31–34, 1984. View at Google Scholar · View at Scopus
  117. S. L. Johnston, “Overview of virus-induced airway disease,” Proceedings of the American Thoracic Society, vol. 2, no. 2, pp. 150–156, 2005. View at Publisher · View at Google Scholar · View at Scopus
  118. M. Yamaya, W. E. Finkbeiner, S. Y. Chun, and J. H. Widdicombe, “Differentiated structure and function of cultures from human tracheal epithelium,” American Journal of Physiology, vol. 262, no. 6, pp. L713–L724, 1992. View at Google Scholar · View at Scopus
  119. H. Yasuda, M. Yamaya, T. Sasaki et al., “Carbocisteine reduces frequency of common colds and exacerbations in patients with chronic obstructive pulmonary disease,” Journal of the American Geriatrics Society, vol. 54, no. 2, pp. 378–380, 2006. View at Publisher · View at Google Scholar · View at Scopus
  120. K. Tatsumi and Y. Fukuchi, “Carbocisteine improves quality of life in patients with chronic obstructive pulmonary disease,” Journal of the American Geriatrics Society, vol. 55, no. 11, pp. 1884–1886, 2007. View at Publisher · View at Google Scholar · View at Scopus
  121. E. J. Bowman, A. Siebers, and K. Altendorf, “Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 21, pp. 7972–7976, 1988. View at Google Scholar · View at Scopus
  122. E. Prchla, E. Kuechler, D. Blaas, and R. Fuchs, “Uncoating of human rhinovirus serotype 2 from late endosomes,” Journal of Virology, vol. 68, no. 6, pp. 3713–3723, 1994. View at Google Scholar · View at Scopus
  123. N. Bayer, E. Prchla, M. Schwab, D. Blaas, and R. Fuchs, “Human rhinovirus HRV14 uncoats from early endosomes in the presence of bafilomycin,” FEBS Letters, vol. 463, no. 1-2, pp. 175–178, 1999. View at Publisher · View at Google Scholar · View at Scopus
  124. J. L. Simpson, H. Powell, M. J. Boyle, R. J. Scott, and P. G. Gibson, “Clarithromycin targets neutrophilic airway inflammation in refractory asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 2, pp. 148–155, 2008. View at Publisher · View at Google Scholar · View at Scopus
  125. T. Suzuki, M. Yanai, M. Yamaya et al., “Erythromycin and common cold in COPD,” Chest, vol. 120, no. 3, pp. 730–733, 2001. View at Publisher · View at Google Scholar · View at Scopus
  126. M. Yamaya, A. Azuma, H. Tanaka et al., “Inhibitory effects of macrolide antibiotics on exacerbations and hospitalization in chronic obstructive pulmonary disease in Japan: a retrospective multicenter analysis,” Journal of the American Geriatrics Society, vol. 56, no. 7, pp. 1358–1360, 2008. View at Publisher · View at Google Scholar · View at Scopus
  127. T. A. R. Seemungal, T. M. A. Wilkinson, J. R. Hurst, W. R. Perera, R. J. Sapsford, and J. A. Wedzicha, “Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations,” American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 11, pp. 1139–1147, 2008. View at Publisher · View at Google Scholar · View at Scopus
  128. Z. Y. He, L. M. Ou, J. Q. Zhang et al., “Effect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in chronic obstructive pulmonary disease,” Respiration, vol. 80, no. 6, pp. 445–452, 2010. View at Publisher · View at Google Scholar · View at Scopus
  129. R. K. Albert, J. Connett, W. C. Bailey et al., “Azithromycin for prevention of exacerbations of COPD,” The New England Journal of Medicine, vol. 365, no. 8, pp. 689–698, 2011. View at Publisher · View at Google Scholar · View at Scopus
  130. H. Ochiai, S. Sakai, T. Hirabayashi, Y. Shimizu, and K. Terasawa, “Inhibitory effect of bafilomycin A1, a specific inhibitor of vacuolar-type proton pump, on the growth of influenza A and B viruses in MDCK cells,” Antiviral Research, vol. 27, no. 4, pp. 425–430, 1995. View at Publisher · View at Google Scholar · View at Scopus